APA (7th ed.) Citation

Bender, L., Meyer, G., Quoix, E., & Mennecier, B. (2019). Ceritinib-related interstitial lung disease improving after treatment cessation without recurrence under either crizotinib or brigatinib: A case report. Annals of translational medicine, 7(5), 106. https://doi.org/10.21037/atm.2019.01.24

Chicago Style (17th ed.) Citation

Bender, Laura, Guillaume Meyer, Elisabeth Quoix, and Bertrand Mennecier. "Ceritinib-related Interstitial Lung Disease Improving After Treatment Cessation Without Recurrence Under Either Crizotinib or Brigatinib: A Case Report." Annals of Translational Medicine 7, no. 5 (2019): 106. https://doi.org/10.21037/atm.2019.01.24.

MLA (9th ed.) Citation

Bender, Laura, et al. "Ceritinib-related Interstitial Lung Disease Improving After Treatment Cessation Without Recurrence Under Either Crizotinib or Brigatinib: A Case Report." Annals of Translational Medicine, vol. 7, no. 5, 2019, p. 106, https://doi.org/10.21037/atm.2019.01.24.